Strategists at HSBC led by Frank Lee lowered their price target on the shares to $110 from $200 and cut the rating to Reduce ...

AI drug creation company Absci Corporation (NASDAQ:ABSI) shares are trading higher in premarket on Wednesday after the ...

Chip maker AMD is investing $20 million in AI drug startup Absci, which will use AMD chips and software for drug development.

HSBC analysts on Wednesday downgraded AMD (NASDAQ:AMD) stock to Reduce from Buy, and nearly halved their price target to $110 ...

AMD announced its Ryzen AI Max processors at CES, ushering in a new series of AMD -based AI PCs and laptops. The chipmaker ...

AMD promised eventual “mobile gaming dominance” back in 2022, and it feels like we’re getting closer every day. Today, the ...

The $20 million deal gives the chip supplier a toehold in the life-sciences market, a strategy it plans to replicate in other ...

Absci Corporation (NASDAQ: ABSI), a data-first generative AI drug creation company, today announced a strategic collaboration with AMD to deploy AMD Instinct™ accelerators and ROCm™ software to power ...

AMD claims the Ryzen 9000 CPUs are up to 8% faster than the previous Ryzen 9 7950X3D, with improvements in games like Black ...

AMD kicks of CES 2025 with a bang: its Ryzen AI Max processor combines discrete-level graphics with powerful AI, all ...

AMD announces its new Ryzen AI Max+ 'Strix Halo' APU with 16 cores, 32 threads of Zen 5 CPU, 40 CUs of RDNA 3.5 GPU, up to ...